Effect of event selection on jetlike correlation measurement in d+Au collisions at sNN=200 GeV

AbstractDihadron correlations are analyzed in sNN=200 GeV d+Au collisions classified by forward charged particle multiplicity and zero-degree neutral energy in the Au-beam direction. It is found that the jetlike correlated yield increases with the event multiplicity. After taking into account this dependence, the non-jet contribution on the away side is minimal, leaving little room for a back-to-back ridge in these collisions

Beam-energy Dependence Of Charge Balance Functions From Au + Au Collisions At Energies Available At The Bnl Relativistic Heavy Ion Collider

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Balance functions have been measured in terms of relative pseudorapidity (Δη) for charged particle pairs at the BNL Relativistic Heavy Ion Collider from Au + Au collisions at sNN=7.7GeV to 200 GeV using the STAR detector. These results are compared with balance functions measured at the CERN Large Hadron Collider from Pb + Pb collisions at sNN=2.76TeV by the ALICE Collaboration. The width of the balance function decreases as the collisions become more central and as the beam energy is increased. In contrast, the widths of the balance functions calculated using shuffled events show little dependence on centrality or beam energy and are larger than the observed widths. Balance function widths calculated using events generated by UrQMD are wider than the measured widths in central collisions and show little centrality dependence. The measured widths of the balance functions in central collisions are consistent with the delayed hadronization of a deconfined quark gluon plasma (QGP). The narrowing of the balance function in central collisions at sNN=7.7 GeV implies that a QGP is still being created at this relatively low energy. © 2016 American Physical Society.942CNPq, Conselho Nacional de Desenvolvimento Científico e TecnológicoMinistry of Education and Science of the Russian FederationMOE, Ministry of Education of the People's Republic of ChinaMOST, Ministry of Science and Technology of the People's Republic of ChinaNRF-2012004024, National Research FoundationNSF, National Stroke FoundationConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

Dielectron Azimuthal Anisotropy At Mid-rapidity In Au+au Collisions At Snn =200 Gev

We report on the first measurement of the azimuthal anisotropy (v2) of dielectrons (e+e- pairs) at mid-rapidity from sNN=200 GeV Au+Au collisions with the STAR detector at the Relativistic Heavy Ion Collider (RHIC), presented as a function of transverse momentum (pT) for different invariant-mass regions. In the mass region Mee<1.1 GeV/c2 the dielectron v2 measurements are found to be consistent with expectations from π0,η,ω, and φ decay contributions. In the mass region 1.1<Mee<2.9GeV/c2, the measured dielectron v2 is consistent, within experimental uncertainties, with that from the cc¯ contributions.906Adams, J., (2005) Nucl. Phys. A, 757, p. 102. , NUPABL 0375-9474Arsene, I., (2005) Nucl. Phys. A, 757, p. 1. , NUPABL 0375-9474Adcox, K., (2005) Nucl. Phys. A, 757, p. 184. , NUPABL 0375-9474Back, B.B., (2005) Nucl. Phys. A, 757, p. 28. , NUPABL 0375-9474Rapp, R., Wambach, J., (2002) Adv. Nucl. Phys., 25, p. 1. , 0065-2970David, G., Rapp, R., Xu, Z., (2008) Phys. Rep., 462, p. 176. , PRPLCM 0370-1573Agakichiev, G., (2005) Eur. Phys. J. C, 41, p. 475. , EPCFFB 1434-6044Arnaldi, R., (2006) Phys. Rev. Lett., 96, p. 162302. , PRLTAO 0031-9007Brown, G.E., Rho, M., (1996) Phys. Rep., 269, p. 333. , PRPLCM 0370-1573Rapp, R., Wambach, J., (1999) Eur. Phys. J. A, 6, p. 415. , EPJAFV 1434-6001Dusling, K., Teaney, D., Zahed, I., (2007) Phys. Rev. C, 75, p. 024908. , PRVCAN 0556-2813Van Hees, H., Rapp, R., (2008) Nucl. Phys. A, 806, p. 339. , NUPABL 0375-9474Renk, T., Ruppert, J., (2008) Phys. Rev. C, 77, p. 024907. , PRVCAN 0556-2813Adare, A., (2010) Phys. Rev. C, 81, p. 034911. , PRVCAN 0556-2813Adamczyk, L., (2014) Phys. Rev. Lett., 113, p. 022301. , a longer version (unpublished). PRLTAO 0031-9007Rapp, R., Wambach, J., Van Hees, H., (2010) Relativistic Heavy-Ion Physics, , in, edited by R. Stock, Landolt Börnstein New Series I/23A (Springer, Berlin), Chap. 4-1Linnyk, O., Cassing, W., Manninen, J., Bratkovskaya, E.L., Ko, C.M., (2012) Phys. Rev. C, 85, p. 024910. , PRVCAN 0556-2813Xu, J.-H., Chen, H.F., Dong, X., Wang, Q., Zhang, Y.F., (2012) Phys. Rev. C, 85, p. 024906. , PRVCAN 0556-2813Adare, A., (2010) Phys. Rev. Lett., 104, p. 132301. , PRLTAO 0031-9007Poskanzer, A.M., Voloshin, S.A., (1998) Phys. Rev. C, 58, p. 1671. , PRVCAN 0556-2813Adare, A., (2012) Phys. Rev. Lett., 109, p. 122302. , PRLTAO 0031-9007Van Hees, H., Gale, C., Rapp, R., (2011) Phys. Rev. C, 84, p. 054906. , PRVCAN 0556-2813Chatterjee, R., Srivastava, D.K., Heinz, U., Gale, C., (2007) Phys. Rev. C, 75, p. 054909. , PRVCAN 0556-2813Adare, A., (2009) Phys. Lett. B, 670, p. 313. , PYLBAJ 0370-2693Bonner, B., (2003) Nucl. Instrum. Methods A, 508, p. 181. , NIMAER 0168-9002Shao, M., (2002) Nucl. Instrum. Methods A, 492, p. 344Wu, J., (2005) Nucl. Instrum. Methods A, 538, p. 243. , NIMAER 0168-9002Landgraf, J.M., (2003) Nucl. Instrum. Methods A, 499, p. 762. , NIMAER 0168-9002Ackermann, K.H., (2003) Nucl. Instrum. Methods A, 499, p. 624. , NIMAER 0168-9002Anderson, M., (2003) Nucl. Instrum. Methods A, 499, p. 659. , NIMAER 0168-9002Bichsel, H., (2006) Nucl. Instrum. Methods A, 562, p. 154. , NIMAER 0168-9002Xu, Y., (2010) Nucl. Instrum. Methods A, 614, p. 28. , NIMAER 0168-9002Shao, M., (2006) Nucl. Instrum. Methods A, 558, p. 419. , NIMAER 0168-9002Adams, J., (2005) Phys. Lett. B, 616, p. 8. , PYLBAJ 0370-2693Ruan, L., Ph.D. thesis, University of Science and Technology of China, 2005, arXiv:nucl-ex/0503018 (unpublished)Llope, W.J., (2004) Nucl. Instrum. Methods A, 522, p. 252. , NIMAER 0168-9002Adler, C., (2002) Phys. Rev. Lett., 89, p. 202301. , PRLTAO 0031-9007Adams, J., (2005) Phys. Rev. Lett., 94, p. 062301. , PRLTAO 0031-9007Adamczyk, L., (2012) Phys. Rev. C, 86, p. 024906. , PRVCAN 0556-2813Zhao, J., (2013), https://drupal.star.bnl.gov/STAR/theses/phd-32, Ph.D. thesis, Shanghai Institute of Applied Physics, (unpublished)Voloshin, S.A., Poskanzer, A.M., Snellings, R., (2010) Relativistic Heavy Ion Physics, pp. 5-54. , in, Landolt-Börnstein Vol. 1/23 (Springer-Verlag, Berlin), ppAdamczyk, L., (2013) Phys. Rev. C, 88, p. 014902. , PRVCAN 0556-2813Abelev, B.I., (2008) Phys. Rev. C, 77, p. 054901. , PRVCAN 0556-2813Abelev, B.I., (2006) Phys. Rev. Lett., 97, p. 152301. , PRLTAO 0031-9007Abelev, B.I., (2009) Phys. Rev. C, 79, p. 034909. , PRVCAN 0556-2813Abelev, B.I., (2009) Phys. Rev. C, 79, p. 064903. , PRVCAN 0556-2813Adams, J., (2005) Phys. Lett. B, 612, p. 181. , PYLBAJ 0370-2693Adler, S.S., (2007) Phys. Rev. C, 75, p. 024909. , PRVCAN 0556-2813Tang, Z., Xu, Y., Ruan, L., Van Buren, G., Wang, F., Xu, Z., (2009) Phys. Rev. C, 79, p. 051901. , (R) () PRVCAN 0556-2813Shao, M., Yi, L., Tang, Z., Chen, H., Li, C., Xu, Z., (2010) J. Phys. G, 37, p. 085104. , JPGPED 0954-3899Afanasiev, S., (2009) Phys. Rev. C, 80, p. 054907. , PRVCAN 0556-2813Adams, J., (2005) Phys. Rev. C, 72, p. 014904. , PRVCAN 0556-2813Abelev, B.I., (2007) Phys. Rev. Lett., 99, p. 112301. , PRLTAO 0031-9007Kroll, N.M., Wada, W., (1955) Phys. Rev., 98, p. 1355. , PHRVAO 0031-899XRuan, L., (2011) Nucl. Phys. A, 855, p. 269. , NUPABL 0375-9474Huang, B., (2011), Ph.D. thesis, University of Science and Technology of China, (unpublished)Sjöstrand, T., (2001) Comput. Phys. Commun., 135, p. 238. , CPHCBZ 0010-4655Adamczyk, L., (2012) Phys. Rev. D, 86, p. 072013. , PRVDAQ 1550-7998Agakishiev, H., (2011) Phys. Rev. D, 83, p. 052006. , PRVDAQ 1550-7998Adare, A., (2011) Phys. Rev. C, 84, p. 044905. , PRVCAN 0556-2813Adare, A., (2012) Phys. Rev. C, 85, p. 064914. , PRVCAN 0556-2813Adare, A., (2007) Phys. Rev. Lett., 98, p. 162301. , PRLTAO 0031-9007Adams, J., (2004) Phys. Rev. Lett., 92, p. 052302. , PRLTAO 0031-9007Vujanovic, G., Young, C., Schenke, B., Jeon, S., Rapp, R., Gale, C., (2013) Nucl. Phys. A, 904-905, p. 557c. , NUPABL 0375-9474Vujanovic, G., Young, C., Schenke, B., Jeon, S., Rapp, R., Gale, C., (2014) Phys. Rev. C, 89, p. 034904. , PRVCAN 0556-281

J/ψ Production At Low Pt In Au+au And Cu+cu Collisions At Snn =200 Gev With The Star Detector

The J/ψ pT spectrum and nuclear modification factor (RAA) are reported for pT<5GeV/c and |y|<1 from 0% to 60% central Au+Au and Cu+Cu collisions at sNN=200GeV at STAR. A significant suppression of pT-integrated J/ψ production is observed in central Au+Au events. The Cu+Cu data are consistent with no suppression, although the precision is limited by the available statistics. RAA in Au+Au collisions exhibits a strong suppression at low transverse momentum and gradually increases with pT. The data are compared to high-pT STAR results and previously published BNL Relativistic Heavy Ion Collider results. Comparing with model calculations, it is found that the invariant yields at low pT are significantly above hydrodynamic flow predictions but are consistent with models that include color screening and regeneration. © 2014 American Physical Society.902CNRS/IN2P3; NSF; Arthritis National Research Foundation; NRF-2012004024; ANRF; Arthritis National Research FoundationMatsui, T., Satz, H., (1986) Phys Lett. B, 178, p. 416. , PYLBAJ 0370-2693 10.1016/0370-2693(86)91404-8Digal, S., Petreczky, P., Satz, H., (2001) Phys. Rev. D, 64, p. 094015. , 0556-2821 10.1103/PhysRevD.64.094015Karsch, F., Kharzeev, D., Satz, H., Sequential charmonium dissociation (2006) Physics Letters, Section B: Nuclear, Elementary Particle and High-Energy Physics, 637 (1-2), pp. 75-80. , DOI 10.1016/j.physletb.2006.03.078, PII S037026930600445XBraun-Munzinger, P., Stachel, J., The quest for the quark-gluon plasma (2007) Nature, 448 (7151), pp. 302-309. , DOI 10.1038/nature06080, PII NATURE06080Abreu, M.C., (1999) Phys. Lett. B, 449, p. 128. , (NA38 Collaboration),. PYLBAJ 0370-2693 10.1016/S0370-2693(99)00057-XAbreu, M.C., (1997) Phys. Lett. B, 410, p. 327. , (NA50 Collaboration),. PYLBAJ 0370-2693 10.1016/S0370-2693(97)00914-3Arnaldi, R., Banicz, K., Castor, J., Chaurand, B., Cicalo, C., Colla, A., Cortese, P., Wohri, H.K., J/ψ production in indium-indium collisions at 158GeV/nucleon (2007) Physical Review Letters, 99 (13), p. 132302. , http://oai.aps.org/oai?verb=GetRecord&Identifier=oai:aps.org: PhysRevLett.99.132302&metadataPrefix=oai_apsmeta_2, DOI 10.1103/PhysRevLett.99.132302Adare, A., Afanasiev, S., Aidala, C., Ajitanand, N.N., Akiba, Y., Al-Bataineh, H., Alexander, J., Al-Jamel, A., J/ψ production versus centrality, transverse momentum, and rapidity in Au+Au collisions at s NN=200 GeV (2007) Physical Review Letters, 98 (23), p. 232301. , http://oai.aps.org/oai?verb=GetRecord&Identifier=oai:aps.org: PhysRevLett.98.232301&metadataPrefix=oai_apsmeta_2, DOI 10.1103/PhysRevLett.98.232301Adamczyk, L., (2013) Phys. Lett. B, 722, p. 55. , (STAR Collaboration),. PYLBAJ 0370-2693 10.1016/j.physletb.2013.04.010Abelev, B., (2012) Phys. Rev. Lett., 109, p. 072301. , (ALICE Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.109.072301Chatrchyan, S., (2012) J. High Energy Phys., (5), p. 063. , (CMS Collaboration),. JHEPFG 1029-8479 10.1007/JHEP05(2012)063Braun-Munzinger, P., Stachel, J., (2000) Phys. Lett. B, 490, p. 196. , PYLBAJ 0370-2693 10.1016/S0370-2693(00)00991-6Grandchamp, L., Rapp, R., (2002) Nucl. Phys. A, 709, p. 415. , NUPABL 0375-9474 10.1016/S0375-9474(02)01027-8Gavin, S., Vogt, R., (1996) Nucl. Phys. A, 610, p. 442. , NUPABL 0375-9474 10.1016/S0375-9474(96)00376-4Capella, A., (1997) Phys. Lett. B, 393, p. 431. , PYLBAJ 0370-2693 10.1016/S0370-2693(96)01650-4Karsch, F., Petronzio, P., (1988) Z. Phys. C, 37, p. 627. , ZPCFD2 0170-9739 10.1007/BF01549724Adare, A., (2012) Phys. Rev. D, 85, p. 092004. , (PHENIX Collaboration),. 10.1103/PhysRevD.85.092004Charm, beauty and charmonium production at HERA-B (2005) European Physical Journal C, 43 (1-4), pp. 179-186. , DOI 10.1140/epjc/s2005-02308-8Vogt, R., Shadowing and absorption effects on J/ψ production in da collisions (2005) Physical Review C - Nuclear Physics, 71 (5), pp. 1-11. , http://oai.aps.org/oai/?verb=ListRecords&metadataPrefix= oai_apsmeta_2&set=journal:PRC:71, DOI 10.1103/PhysRevC.71.054902, 054902Gavin, S., Gyulassy, M., (1988) Phys. Lett. B, 214, p. 241. , PYLBAJ 0370-2693 10.1016/0370-2693(88)91476-1Noble, J.V., (1981) Phys. Rev. Lett., 46, p. 412. , PRLTAO 0031-9007 10.1103/PhysRevLett.46.412Tram, V., Arleo, F., (2009) Eur. Phys. J. C, 61, p. 847. , EPCFFB 1434-6044 10.1140/epjc/s10052-009-0864-yAlde, D., Baer, H., Carey, T., Garvey, G., Klein, A., (1991) Phys. Rev. Lett., 66, p. 133. , PRLTAO 0031-9007 10.1103/PhysRevLett.66.133Leitch, M., (1992) Nucl. Phys. A, 544, p. 197. , (E772 and E789 Collaboration),. NUPABL 0375-9474 10.1016/0375-9474(92) 90574-4Leitch, M., (2000) Phys. Rev. Lett., 84, p. 3256. , (NuSea Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.84.3256Alessandro, B., Alexa, C., Arnaldi, R., Atayan, M., Baglin, C., Baldit, A., Beole, S., Willis, N., Charmonium production and nuclear absorption in p-A interactions at 450 GeV (2004) European Physical Journal C, 33 (1), pp. 31-40. , DOI 10.1140/epjc/s2003-01539-yAlessandro, B., Alexa, C., Arnaldi, R., Atayan, M., Beole, S., Boldea, V., Bordalo, P., Wu, T., A new measurement of J/ψ suppression in Pb-Pb collisions at 158 GeV per nucleon (2005) European Physical Journal C, 39 (3), pp. 335-345. , DOI 10.1140/epjc/s2004-02107-9Arnaldi, R., (2012) Phys. Lett. B, 706, p. 263. , (NA60 Collaboration),. PYLBAJ 0370-2693 10.1016/j.physletb.2011.11.042Adare, A., (2013) Phys. Rev. C, 87, p. 034904. , (PHENIX Collaboration),. 10.1103/PhysRevC.87.034904Adare, A., (2013) Phys. Rev. Lett., 111, p. 202301. , (PHENIX Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.111.202301Adare, A., (2011) Phys. Rev. Lett., 107, p. 142301. , (PHENIX Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.107.142301Zhao, X., Rapp, R., (2010) Phys. Rev. C, 82, p. 064905. , PRVCAN 0556-2813 10.1103/PhysRevC.82.064905Adamczyk, L., (2013) Phys. Rev. Lett., 111, p. 052301. , (STAR Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.111.052301Ackermann, K.H., Adams, N., Adler, C., Ahammed, Z., Ahmad, S., Allgower, C., Amonett, J., Harris, J.W., STAR detector overview (2003) Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 499 (2-3), pp. 624-632. , DOI 10.1016/S0168-9002(02)01960-5Llope, W.J., (2004) Nucl. Instrum. Methods Phys. Res., Sect. A, 522, p. 252. , NIMAER 0168-9002 10.1016/j.nima.2003.11.414Adler, C., Denisov, A., Garcia, E., Murray, M., Strobele, H., White, S., The RHIC zero-degree calorimeters (2003) Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 499 (2-3), pp. 433-436. , DOI 10.1016/j.nima.2003.08.112Llope, W., (2012) Nucl. Instrum. Methods Phys. Res., Sect. A, 661, pp. S110. , (Suppl. 1),. NIMAER 0168-9002 10.1016/j.nima.2010.07.086Reed, R., (2010) J. Phys.: Conf. Ser., 219, p. 03020. , 1742-6596 10.1088/1742-6596/219/3/032020Beringer, J., (2012) Phys. Rev. D, 86, p. 010001. , (Particle Data Group),. 10.1103/PhysRevD.86.010001Beddo, M., Bielick, E., Fornek, T., Guarino, V., Hill, D., Krueger, K., LeCompte, T., Suaide, A.A.P., The STAR barrel electromagnetic calorimeter (2003) Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 499 (2-3), pp. 725-739. , DOI 10.1016/S0168-9002(02)01970-8Miller, M.L., Reygers, K., Sanders, S.J., Steinberg, P., (2007) Annu. Rev. Nucl. Part. Sci., 57, p. 205. , ARPSDF 0163-8998 10.1146/annurev.nucl.57.090506.123020Abelev, B.I., (2009) Phys. Lett. B, 673, p. 183. , (STAR Collaboration),. PYLBAJ 0370-2693 10.1016/j.physletb.2009.02.037Bichsel, H., A method to improve tracking and particle identification in TPCs and silicon detectors (2006) Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 562 (1), pp. 154-197. , DOI 10.1016/j.nima.2006.03.009, PII S0168900206005353Shao, M., (2006) Nucl. Instrum. Methods Phys. Res., Sect. A, 558, p. 419. , NIMAER 0168-9002 10.1016/j.nima.2005.11.251Abelev, B.I., (2009) Phys. Rev. C, 79, p. 034909. , (STAR Collaboration),. PRVCAN 0556-2813 10.1103/PhysRevC.79.034909Adamczyk, L., (STAR Collaboration), arXiv:1402.1791Spiridonov, A., arXiv:hep-ex/0510076Abelev, B.I., (2009) Phys. Rev. C, 80, p. 041902. , (STAR Collaboration),. PRVCAN 0556-2813 10.1103/PhysRevC.80.041902Tang, Z., Xu, Y., Ruan, L., Van Buren, G., Wang, F., Xu, Z., (2009) Phys. Rev. C, 79, p. 051901. , PRVCAN 0556-2813 10.1103/PhysRevC.79.051901Tang, Z., Yi, L., Ruan, L., Shao, M., Chen, H., (2013) Chin. Phys. Lett., 30, p. 031201. , CPLEEU 0256-307X 10.1088/0256-307X/30/3/031201Adare, A., (2010) Phys. Rev. D, 82, p. 012001. , (PHENIX Collaboration),. 10.1103/PhysRevD.82.012001Liu, Y., Qu, Z., Xu, N., Zhuang, P., (2009) Phys. Lett. B, 678, p. 72. , PYLBAJ 0370-2693 10.1016/j.physletb.2009.06.006Heinz, U.W., Shen, C., (private communication)Adare, A., (2008) Phys. Rev. Lett., 101, p. 122301. , (PHENIX Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.101.122301Adams, J., (2003) Phys. Rev. Lett, 91, p. 172302. , (STAR Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.91.172302Adare, A., Afanasiev, S., Aidala, C., Ajitanand, N.N., Akiba, Y., Al-Bataineh, H., Alexander, J., Aoki, K., J/ψ Production versus transverse momentum and rapidity in p+p collisions at s=200GeV (2007) Physical Review Letters, 98 (23), p. 232002. , http://oai.aps.org/oai?verb=GetRecord&Identifier=oai:aps.org: PhysRevLett.98.232002&metadataPrefix=oai_apsmeta_2, DOI 10.1103/PhysRevLett.98.232002Zhao, X., Rapp, R., (2008) Phys. Lett. B, 664, p. 253. , PYLBAJ 0370-2693 10.1016/j.physletb.2008.03.06

Beam-energy Dependence Of Charge Separation Along The Magnetic Field In Au+au Collisions At Rhic

Local parity-odd domains are theorized to form inside a quark-gluon plasma which has been produced in high-energy heavy-ion collisions. The local parity-odd domains manifest themselves as charge separation along the magnetic field axis via the chiral magnetic effect. The experimental observation of charge separation has previously been reported for heavy-ion collisions at the top RHIC energies. In this Letter, we present the results of the beam-energy dependence of the charge correlations in Au+Au collisions at midrapidity for center-of-mass energies of 7.7, 11.5, 19.6, 27, 39, and 62.4 GeV from the STAR experiment. After background subtraction, the signal gradually reduces with decreased beam energy and tends to vanish by 7.7 GeV. This implies the dominance of hadronic interactions over partonic ones at lower collision energies. © 2014 American Physical Society.1135DOE; National Research Foundation; CNRS/IN2P3; NSF; National Research Foundation; NRF-2012004024; National Research FoundationVafa, C., Witten, E., (1984) Phys. Rev. Lett., 53, p. 535. , PRLTAO 0031-9007 10.1103/PhysRevLett.53.535Lee, D.T., (1973) Phys. Rev. D, 8, p. 1226. , PRVDAQ 0556-2821 10.1103/PhysRevD.8.1226Lee, T.D., Wick, G.C., (1974) Phys. Rev. D, 9, p. 2291. , PRVDAQ 0556-2821 10.1103/PhysRevD.9.2291Kharzeev, D.E., McLerran, L.D., Warringa, H.J., (2008) Nucl. Phys., A803, p. 227. , NUPBBO 0375-9474 10.1016/j.nuclphysa.2008.02.298Kharzeev, D., (2006) Phys. Lett. B, 633, p. 260. , PYLBAJ 0370-2693 10.1016/j.physletb.2005.11.075Kharzeev, D., Zhitnitsky, A., (2007) Nucl. Phys., A797, p. 67. , NUPBBO 0375-9474 10.1016/j.nuclphysa.2007.10.001Fukushima, K., Kharzeev, D.E., Warringa, H.J., (2008) Phys. Rev. D, 78, p. 074033. , PRVDAQ 1550-7998 10.1103/PhysRevD.78.074033Kharzeev, E.D., (2010) Ann. Phys. (Amsterdam), 325, p. 205. , APNYA6 0003-4916 10.1016/j.aop.2009.11.002Gatto, R., Ruggieri, M., (2012) Phys. Rev. D, 85, p. 054013. , PRVDAQ 1550-7998 10.1103/PhysRevD.85.054013Abelev, B.I., (2009) Phys. Rev. Lett., 103, p. 251601. , (STAR Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.103.251601Abelev, B.I., (2010) Phys. Rev. C, 81, p. 054908. , (STAR Collaboration),. PRVCAN 0556-2813 10.1103/PhysRevC.81.054908Adamczyk, L., (2013) Phys. Rev. C, 88, p. 064911. , (STAR Collaboration),. PRVCAN 0556-2813 10.1103/PhysRevC.88.064911Adamczyk, L., (2014) Phys. Rev. C, 89, p. 044908. , (STAR Collaboration),. PRVCAN 0556-2813 10.1103/PhysRevC.89.044908Ajitanand, N.N., Esumi, S., Lacey, R.A., Proceedings of the RBRC Workshops, 2010, 96. , http://www.bnl.gov/isd/documents/74466.pdf, (PHENIX Collaboration), in, Vol.Ajitanand, N.N., Lacey, R.A., Taranenko, A., Alexander, J.M., (2011) Phys. Rev. C, 83, p. 011901. , PRVCAN 0556-2813 10.1103/PhysRevC.83.011901Abelev, B.I., (2013) Phys. Rev. Lett., 110, p. 012301. , (ALICE Collaboration),. PRLTAO 0031-9007 10.1103/PhysRevLett.110.012301Bzdak, A., Koch, V., Liao, J., (2010) Phys. Rev. C, 81, p. 031901. , PRVCAN 0556-2813 10.1103/PhysRevC.81.031901Liao, J., Koch, V., Bzdak, A., (2010) Phys. Rev. C, 82, p. 054902. , PRVCAN 0556-2813 10.1103/PhysRevC.82.054902Kharzeev, D.E., Son, D.T., (2011) Phys. Rev. Lett., 106, p. 062301. , PRLTAO 0031-9007 10.1103/PhysRevLett.106.062301Voloshin, A.S., (2004) Phys. Rev. C, 70, p. 057901. , PRVCAN 0556-2813 10.1103/PhysRevC.70.057901Anderson, M., (2003) Nucl. Instrum. Methods Phys. Res., Sect. A, 499, p. 659. , NIMAER 0168-9002 10.1016/S0168-9002(02)01964-2Adams, J., (2005) Phys. Rev. C, 72, p. 014904. , (STAR Collaboration), ()PRVCAN 0556-2813 10.1103/PhysRevC.72.014904Agakishiev, G., (2012) Phys. Rev. C, 86, p. 014904. , (STAR Collaboration), ()PRVCAN 0556-2813 10.1103/PhysRevC.86.014904Adamczyk, L., (2012) Phys. Rev. C, 86, p. 054908. , (STAR Collaboration),. PRVCAN 0556-2813 10.1103/PhysRevC.86.054908Poskanzer, A.M., Voloshin, S.A., (1998) Phys. Rev. C, 58, p. 1671. , PRVCAN 0556-2813 10.1103/PhysRevC.58.1671Barrette, J., (1997) Phys. Rev. C, 56, p. 3254. , PRVCAN 0556-2813 10.1103/PhysRevC.56.3254Ollitrault, J.-Y., Poskanzer, A.M., Voloshin, S.A., (2009) Phys. Rev. C, 80, p. 014904. , PRVCAN 0556-2813 10.1103/PhysRevC.80.014904Abelev, B.I., (2008) Phys. Rev. Lett., 101, p. 252301. , (STAR Collaboration), () and references therein. PRLTAO 0031-9007 10.1103/PhysRevLett.101.252301Bzdak, A., Koch, V., Liao, J., (2011) Phys. Rev. C, 83, p. 014905. , PRVCAN 0556-2813 10.1103/PhysRevC.83.014905Ray, R.L., Longacre, R.S., arXiv:nucl-ex/0008009;Ray, R.L., Longacre, R.S., (private communication)Bass, S.A., (1998) Prog. Part. Nucl. Phys., 41, p. 255. , PPNPDB 0146-6410 10.1016/S0146-6410(98)00058-1Bleicher, M., (1999) J. Phys. G, 25, p. 1859. , JPGPED 0954-3899 10.1088/0954-3899/25/9/308Ma, G.-L., Zhang, B., (2011) Phys. Lett. B, 700, p. 39. , PYLBAJ 0370-2693 10.1016/j.physletb.2011.04.057Okorokov, A.V., (2013) Int. J. Mod. Phys. e, 22, p. 1350041. , IMPEER 0218-3013 10.1142/S0218301313500419Bzdak, A., Koch, V., Liao, J., (2013) Lect. Notes Phys., 871, p. 503. , LNPHA4 0075-8450 10.1007/978-3-642-37305-

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Accurate assessments of current and future fertility—including overall trends and changing population age structures across countries and regions—are essential to help plan for the profound social, economic, environmental, and geopolitical challenges that these changes will bring. Estimates and projections of fertility are necessary to inform policies involving resource and health-care needs, labour supply, education, gender equality, and family planning and support. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 produced up-to-date and comprehensive demographic assessments of key fertility indicators at global, regional, and national levels from 1950 to 2021 and forecast fertility metrics to 2100 based on a reference scenario and key policy-dependent alternative scenarios. Methods: To estimate fertility indicators from 1950 to 2021, mixed-effects regression models and spatiotemporal Gaussian process regression were used to synthesise data from 8709 country-years of vital and sample registrations, 1455 surveys and censuses, and 150 other sources, and to generate age-specific fertility rates (ASFRs) for 5-year age groups from age 10 years to 54 years. ASFRs were summed across age groups to produce estimates of total fertility rate (TFR). Livebirths were calculated by multiplying ASFR and age-specific female population, then summing across ages 10–54 years. To forecast future fertility up to 2100, our Institute for Health Metrics and Evaluation (IHME) forecasting model was based on projections of completed cohort fertility at age 50 years (CCF50; the average number of children born over time to females from a specified birth cohort), which yields more stable and accurate measures of fertility than directly modelling TFR. CCF50 was modelled using an ensemble approach in which three sub-models (with two, three, and four covariates variously consisting of female educational attainment, contraceptive met need, population density in habitable areas, and under-5 mortality) were given equal weights, and analyses were conducted utilising the MR-BRT (meta-regression—Bayesian, regularised, trimmed) tool. To capture time-series trends in CCF50 not explained by these covariates, we used a first-order autoregressive model on the residual term. CCF50 as a proportion of each 5-year ASFR was predicted using a linear mixed-effects model with fixed-effects covariates (female educational attainment and contraceptive met need) and random intercepts for geographical regions. Projected TFRs were then computed for each calendar year as the sum of single-year ASFRs across age groups. The reference forecast is our estimate of the most likely fertility future given the model, past fertility, forecasts of covariates, and historical relationships between covariates and fertility. We additionally produced forecasts for multiple alternative scenarios in each location: the UN Sustainable Development Goal (SDG) for education is achieved by 2030; the contraceptive met need SDG is achieved by 2030; pro-natal policies are enacted to create supportive environments for those who give birth; and the previous three scenarios combined. Uncertainty from past data inputs and model estimation was propagated throughout analyses by taking 1000 draws for past and present fertility estimates and 500 draws for future forecasts from the estimated distribution for each metric, with 95% uncertainty intervals (UIs) given as the 2·5 and 97·5 percentiles of the draws. To evaluate the forecasting performance of our model and others, we computed skill values—a metric assessing gain in forecasting accuracy—by comparing predicted versus observed ASFRs from the past 15 years (2007–21). A positive skill metric indicates that the model being evaluated performs better than the baseline model (here, a simplified model holding 2007 values constant in the future), and a negative metric indicates that the evaluated model performs worse than baseline. Findings: During the period from 1950 to 2021, global TFR more than halved, from 4·84 (95% UI 4·63–5·06) to 2·23 (2·09–2·38). Global annual livebirths peaked in 2016 at 142 million (95% UI 137–147), declining to 129 million (121–138) in 2021. Fertility rates declined in all countries and territories since 1950, with TFR remaining above 2·1—canonically considered replacement-level fertility—in 94 (46·1%) countries and territories in 2021. This included 44 of 46 countries in sub-Saharan Africa, which was the super-region with the largest share of livebirths in 2021 (29·2% [28·7–29·6]). 47 countries and territories in which lowest estimated fertility between 1950 and 2021 was below replacement experienced one or more subsequent years with higher fertility; only three of these locations rebounded above replacement levels. Future fertility rates were projected to continue to decline worldwide, reaching a global TFR of 1·83 (1·59–2·08) in 2050 and 1·59 (1·25–1·96) in 2100 under the reference scenario. The number of countries and territories with fertility rates remaining above replacement was forecast to be 49 (24·0%) in 2050 and only six (2·9%) in 2100, with three of these six countries included in the 2021 World Bank-defined low-income group, all located in the GBD super-region of sub-Saharan Africa. The proportion of livebirths occurring in sub-Saharan Africa was forecast to increase to more than half of the world's livebirths in 2100, to 41·3% (39·6–43·1) in 2050 and 54·3% (47·1–59·5) in 2100. The share of livebirths was projected to decline between 2021 and 2100 in most of the six other super-regions—decreasing, for example, in south Asia from 24·8% (23·7–25·8) in 2021 to 16·7% (14·3–19·1) in 2050 and 7·1% (4·4–10·1) in 2100—but was forecast to increase modestly in the north Africa and Middle East and high-income super-regions. Forecast estimates for the alternative combined scenario suggest that meeting SDG targets for education and contraceptive met need, as well as implementing pro-natal policies, would result in global TFRs of 1·65 (1·40–1·92) in 2050 and 1·62 (1·35–1·95) in 2100. The forecasting skill metric values for the IHME model were positive across all age groups, indicating that the model is better than the constant prediction. Interpretation: Fertility is declining globally, with rates in more than half of all countries and territories in 2021 below replacement level. Trends since 2000 show considerable heterogeneity in the steepness of declines, and only a small number of countries experienced even a slight fertility rebound after their lowest observed rate, with none reaching replacement level. Additionally, the distribution of livebirths across the globe is shifting, with a greater proportion occurring in the lowest-income countries. Future fertility rates will continue to decline worldwide and will remain low even under successful implementation of pro-natal policies. These changes will have far-reaching economic and societal consequences due to ageing populations and declining workforces in higher-income countries, combined with an increasing share of livebirths among the already poorest regions of the world. Funding: Bill & Melinda Gates Foundation

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 risk factors in 204 countries and territories and 811 subnational locations, from 1990 to 2021. Methods: The GBD 2021 risk factor analysis used data from 54 561 total distinct sources to produce epidemiological estimates for 88 risk factors and their associated health outcomes for a total of 631 risk–outcome pairs. Pairs were included on the basis of data-driven determination of a risk–outcome association. Age-sex-location-year-specific estimates were generated at global, regional, and national levels. Our approach followed the comparative risk assessment framework predicated on a causal web of hierarchically organised, potentially combinative, modifiable risks. Relative risks (RRs) of a given outcome occurring as a function of risk factor exposure were estimated separately for each risk–outcome pair, and summary exposure values (SEVs), representing risk-weighted exposure prevalence, and theoretical minimum risk exposure levels (TMRELs) were estimated for each risk factor. These estimates were used to calculate the population attributable fraction (PAF; ie, the proportional change in health risk that would occur if exposure to a risk factor were reduced to the TMREL). The product of PAFs and disease burden associated with a given outcome, measured in disability-adjusted life-years (DALYs), yielded measures of attributable burden (ie, the proportion of total disease burden attributable to a particular risk factor or combination of risk factors). Adjustments for mediation were applied to account for relationships involving risk factors that act indirectly on outcomes via intermediate risks. Attributable burden estimates were stratified by Socio-demographic Index (SDI) quintile and presented as counts, age-standardised rates, and rankings. To complement estimates of RR and attributable burden, newly developed burden of proof risk function (BPRF) methods were applied to yield supplementary, conservative interpretations of risk–outcome associations based on the consistency of underlying evidence, accounting for unexplained heterogeneity between input data from different studies. Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2·5th and 97·5th percentile values across the draws. Findings: Among the specific risk factors analysed for this study, particulate matter air pollution was the leading contributor to the global disease burden in 2021, contributing 8·0% (95% UI 6·7–9·4) of total DALYs, followed by high systolic blood pressure (SBP; 7·8% [6·4–9·2]), smoking (5·7% [4·7–6·8]), low birthweight and short gestation (5·6% [4·8–6·3]), and high fasting plasma glucose (FPG; 5·4% [4·8–6·0]). For younger demographics (ie, those aged 0–4 years and 5–14 years), risks such as low birthweight and short gestation and unsafe water, sanitation, and handwashing (WaSH) were among the leading risk factors, while for older age groups, metabolic risks such as high SBP, high body-mass index (BMI), high FPG, and high LDL cholesterol had a greater impact. From 2000 to 2021, there was an observable shift in global health challenges, marked by a decline in the number of all-age DALYs broadly attributable to behavioural risks (decrease of 20·7% [13·9–27·7]) and environmental and occupational risks (decrease of 22·0% [15·5–28·8]), coupled with a 49·4% (42·3–56·9) increase in DALYs attributable to metabolic risks, all reflecting ageing populations and changing lifestyles on a global scale. Age-standardised global DALY rates attributable to high BMI and high FPG rose considerably (15·7% [9·9–21·7] for high BMI and 7·9% [3·3–12·9] for high FPG) over this period, with exposure to these risks increasing annually at rates of 1·8% (1·6–1·9) for high BMI and 1·3% (1·1–1·5) for high FPG. By contrast, the global risk-attributable burden and exposure to many other risk factors declined, notably for risks such as child growth failure and unsafe water source, with age-standardised attributable DALYs decreasing by 71·5% (64·4–78·8) for child growth failure and 66·3% (60·2–72·0) for unsafe water source. We separated risk factors into three groups according to trajectory over time: those with a decreasing attributable burden, due largely to declining risk exposure (eg, diet high in trans-fat and household air pollution) but also to proportionally smaller child and youth populations (eg, child and maternal malnutrition); those for which the burden increased moderately in spite of declining risk exposure, due largely to population ageing (eg, smoking); and those for which the burden increased considerably due to both increasing risk exposure and population ageing (eg, ambient particulate matter air pollution, high BMI, high FPG, and high SBP). Interpretation: Substantial progress has been made in reducing the global disease burden attributable to a range of risk factors, particularly those related to maternal and child health, WaSH, and household air pollution. Maintaining efforts to minimise the impact of these risk factors, especially in low SDI locations, is necessary to sustain progress. Successes in moderating the smoking-related burden by reducing risk exposure highlight the need to advance policies that reduce exposure to other leading risk factors such as ambient particulate matter air pollution and high SBP. Troubling increases in high FPG, high BMI, and other risk factors related to obesity and metabolic syndrome indicate an urgent need to identify and implement interventions. Funding: Bill & Melinda Gates Foundation

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. Methods: The GBD 2021 disease and injury burden analysis estimated years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries using 100 983 data sources. Data were extracted from vital registration systems, verbal autopsies, censuses, household surveys, disease-specific registries, health service contact data, and other sources. YLDs were calculated by multiplying cause-age-sex-location-year-specific prevalence of sequelae by their respective disability weights, for each disease and injury. YLLs were calculated by multiplying cause-age-sex-location-year-specific deaths by the standard life expectancy at the age that death occurred. DALYs were calculated by summing YLDs and YLLs. HALE estimates were produced using YLDs per capita and age-specific mortality rates by location, age, sex, year, and cause. 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws. Uncertainty was propagated at each step of the estimation process. Counts and age-standardised rates were calculated globally, for seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations, from 1990 to 2021. Here we report data for 2010 to 2021 to highlight trends in disease burden over the past decade and through the first 2 years of the COVID-19 pandemic. Findings: Global DALYs increased from 2·63 billion (95% UI 2·44–2·85) in 2010 to 2·88 billion (2·64–3·15) in 2021 for all causes combined. Much of this increase in the number of DALYs was due to population growth and ageing, as indicated by a decrease in global age-standardised all-cause DALY rates of 14·2% (95% UI 10·7–17·3) between 2010 and 2019. Notably, however, this decrease in rates reversed during the first 2 years of the COVID-19 pandemic, with increases in global age-standardised all-cause DALY rates since 2019 of 4·1% (1·8–6·3) in 2020 and 7·2% (4·7–10·0) in 2021. In 2021, COVID-19 was the leading cause of DALYs globally (212·0 million [198·0–234·5] DALYs), followed by ischaemic heart disease (188·3 million [176·7–198·3]), neonatal disorders (186·3 million [162·3–214·9]), and stroke (160·4 million [148·0–171·7]). However, notable health gains were seen among other leading communicable, maternal, neonatal, and nutritional (CMNN) diseases. Globally between 2010 and 2021, the age-standardised DALY rates for HIV/AIDS decreased by 47·8% (43·3–51·7) and for diarrhoeal diseases decreased by 47·0% (39·9–52·9). Non-communicable diseases contributed 1·73 billion (95% UI 1·54–1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5–9·5). Between 2010 and 2021, among the 25 leading Level 3 causes, age-standardised DALY rates increased most substantially for anxiety disorders (16·7% [14·0–19·8]), depressive disorders (16·4% [11·9–21·3]), and diabetes (14·0% [10·0–17·4]). Age-standardised DALY rates due to injuries decreased globally by 24·0% (20·7–27·2) between 2010 and 2021, although improvements were not uniform across locations, ages, and sexes. Globally, HALE at birth improved slightly, from 61·3 years (58·6–63·6) in 2010 to 62·2 years (59·4–64·7) in 2021. However, despite this overall increase, HALE decreased by 2·2% (1·6–2·9) between 2019 and 2021. Interpretation: Putting the COVID-19 pandemic in the context of a mutually exclusive and collectively exhaustive list of causes of health loss is crucial to understanding its impact and ensuring that health funding and policy address needs at both local and global levels through cost-effective and evidence-based interventions. A global epidemiological transition remains underway. Our findings suggest that prioritising non-communicable disease prevention and treatment policies, as well as strengthening health systems, continues to be crucially important. The progress on reducing the burden of CMNN diseases must not stall; although global trends are improving, the burden of CMNN diseases remains unacceptably high. Evidence-based interventions will help save the lives of young children and mothers and improve the overall health and economic conditions of societies across the world. Governments and multilateral organisations should prioritise pandemic preparedness planning alongside efforts to reduce the burden of diseases and injuries that will strain resources in the coming decades. Funding: Bill & Melinda Gates Foundation

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. Methods: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model—a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates—with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality—which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. Findings: The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2–100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1–290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1–211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4–48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3–37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7–9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. Interpretation: Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. Funding: Bill & Melinda Gates Foundation